|
Volumn 35, Issue 11, 2000, Pages 824-831
|
Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor
a b c d e f g h i j k l m n o |
Author keywords
H2 receptor antagonist; Proton pump inhibitor; Recurrence rate
|
Indexed keywords
HISTAMINE H2 RECEPTOR ANTAGONIST;
LANSOPRAZOLE;
PROTON PUMP INHIBITOR;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DISEASE CLASSIFICATION;
DUODENOSCOPY;
DUODENUM ULCER;
FEMALE;
GASTROSCOPY;
HELICOBACTER PYLORI;
HUMAN;
MAINTENANCE THERAPY;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RECURRENCE RISK;
RECURRENT PEPTIC ULCER;
STOMACH ULCER;
SYMPTOMATOLOGY;
TREATMENT OUTCOME;
ULCER HEALING;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ADULT;
ANTI-ULCER AGENTS;
DUODENAL ULCER;
FEMALE;
HISTAMINE H2 ANTAGONISTS;
HUMANS;
MALE;
MIDDLE AGED;
OMEPRAZOLE;
PROTON PUMPS;
RECURRENCE;
STOMACH ULCER;
TIME FACTORS;
|
EID: 0033674054
PISSN: 09441174
EISSN: None
Source Type: Journal
DOI: 10.1007/s005350070019 Document Type: Article |
Times cited : (18)
|
References (22)
|